================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
September 27, 2006
Diomed Holdings, Inc.
Delaware 000-32045 84-1480636
(State or other jurisdiction of (Commission File Number) (IRS Employer Identification No.)
incorporation)
1 Dundee Park
Andover, MA 01810
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (978-475-7771)
ITEM 8.01. OTHER EVENTS.
On September 27, 2006, Diomed Holdings, Inc. conducted its previously scheduled
special meeting of stockholders to consider two proposals relating to the
financing transaction, as described in the proxy statement filed on August 25,
2006 and distributed to holders of record of the Registrant's capital stock. The
stockholders approved both of these proposals, and the Company expects to
complete the financing transaction in due course, in accordance with the terms
thereof.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Diomed Holdings, Inc.
(Registrant)
Date: September 27, 2006 By: /s/ DAVID B. SWANK
---------------------
Name: David B. Swank
Title: Chief Financial Officer